Cargando…

Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s)

Singleminded-2s (SIM2s) is a member of the bHLH/PAS family of transcription factors and a key regulator of mammary epithelial cell differentiation. SIM2s is highly expressed in mammary epithelial cells and down regulated in human breast cancer. Loss of Sim2s causes aberrant mouse mammary ductal deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scribner, Kelly C., Behbod, Fariba, Porter, Weston W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469191/ https://www.ncbi.nlm.nih.gov/pubmed/22777354 http://dx.doi.org/10.1038/onc.2012.286

Ejemplares similares

Noncanonical role of singleminded-2s in mitochondrial respiratory chain formation in breast cancer
por: Wall, Steven W., et al.
Publicado: (2023)

ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition
por: Pearson, Scott J., et al.
Publicado: (2018)

Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness
por: Zheng, Ze-Yi, et al.
Publicado: (2022)

SIM2s directed Parkin-mediated mitophagy promotes mammary epithelial cell differentiation
por: Sanchez, Lilia, et al.
Publicado: (2023)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
por: Yu, Li-Na, et al.
Publicado: (2019)

BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression
por: Elsarraj, Hanan S., et al.
Publicado: (2020)

Overall survival is improved when DCIS accompanies invasive breast cancer
por: Kole, Adam J., et al.
Publicado: (2019)

Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer
por: Wyatt, Garhett L., et al.
Publicado: (2019)

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
por: Barnes, N, et al.
Publicado: (2006)

Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion
por: Hayward, Mary-Kate, et al.
Publicado: (2022)

The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
por: Niwińska, Anna, et al.
Publicado: (2021)

Identifying a Highly-Aggressive DCIS Subgroup by Studying Intra-Individual DCIS Heterogeneity among Invasive Breast Cancer Patients
por: Pape-Zambito, Dana, et al.
Publicado: (2014)

Predicting invasive breast cancer versus DCIS in different age groups
por: Ayvaci, Mehmet US, et al.
Publicado: (2014)

Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer
por: Ward, William H., et al.
Publicado: (2019)

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
por: Clark, S E, et al.
Publicado: (2011)

Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis
por: Huo, Cecilia W., et al.
Publicado: (2016)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
por: Magnoni, Francesca, et al.
Publicado: (2023)

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022)

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
por: Johnson, C, et al.
Publicado: (2012)

Postpartum breast cancer progression is driven by semaphorin 7a mediated invasion and survival
por: Tarullo, Sarah E, et al.
Publicado: (2020)

Biological Markers Predictive of Invasive Recurrence in DCIS
por: Nofech-Mozes, Sharon, et al.
Publicado: (2008)

DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer
por: Beetch, Megan, et al.
Publicado: (2020)

Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study
por: Thennavan, Aatish, et al.
Publicado: (2022)

Loss of SIM2s inhibits RAD51 binding and leads to unresolved replication stress
por: Pearson, Scott J., et al.
Publicado: (2019)

Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression
por: Fang, Wei Bin, et al.
Publicado: (2021)

DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
por: Timbres, Jasmine, et al.
Publicado: (2023)

Is palpable DCIS more aggressive than screen-detected DCIS?
por: Balac, Nina, et al.
Publicado: (2022)

Common genetic susceptibility to DCIS and invasive ductal carcinoma
por: Sopik, Victoria, et al.
Publicado: (2016)

The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast
por: Lewis, Gary. D., et al.
Publicado: (2021)

A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity
por: Kaneko, Kensuke, et al.
Publicado: (2022)

Author Correction: DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer
por: Beetch, Megan, et al.
Publicado: (2020)

Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
por: Schmitz, Renée S J M, et al.
Publicado: (2023)

Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study
por: Williams, Lindsay A., et al.
Publicado: (2019)

Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
por: Sarikaya, Ismet, et al.
Publicado: (2020)

Is anti-hormonal treatment in DCIS of the breast a need?
por: Tjalma, WAA
Publicado: (2016)

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
por: Wärnberg, Fredrik, et al.
Publicado: (2021)

Functional analysis of normal and DCIS modified breast myoepithelial cells
por: Allen, M, et al.
Publicado: (2006)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

Mouse‐INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy
por: Hong, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gccrkbfa3roqqedl6dttkd0n0s